These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3275339)

  • 41. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba PF; Chiesa F; Di Leone A; Masetti R
    Eur Rev Med Pharmacol Sci; 2007; 11(5):283-9. PubMed ID: 18074936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy.
    Bitran JD; Samuels B; Trujillo Y; Klein L; Schroeder L; Martinec J
    Clin Cancer Res; 1996 Sep; 2(9):1509-13. PubMed ID: 9816327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant treatment in high-risk breast cancer.
    Jones A
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):156-8. PubMed ID: 8777488
    [No Abstract]   [Full Text] [Related]  

  • 44. [Problems related to inflammatory cancers of the breast].
    Rouëssé J
    Pathol Biol (Paris); 1989 Feb; 37(2):140-1. PubMed ID: 2652065
    [No Abstract]   [Full Text] [Related]  

  • 45. Multimodal therapy for stage-II breast cancer.
    Baum M
    Lancet; 1977 Sep; 2(8037):564. PubMed ID: 95775
    [No Abstract]   [Full Text] [Related]  

  • 46. [Preliminary results of adjuvant chemo- and chemohormonotherapy in breast cancer patients].
    Marinov D; Tsekova V; Koĭnov K; Velikova M
    Khirurgiia (Sofiia); 1988; 41(4):50-5. PubMed ID: 3199738
    [No Abstract]   [Full Text] [Related]  

  • 47. [Adjuvant chemotherapy of breast cancer: persistent controversy].
    Nagel GA
    Klin Wochenschr; 1984 Feb; 62(4):145-8. PubMed ID: 6708397
    [No Abstract]   [Full Text] [Related]  

  • 48. Surgery, kinetics and biological considerations in planning adjuvant therapy protocols.
    Forbes JF
    Prog Clin Biol Res; 1990; 354A():133-46. PubMed ID: 2247485
    [No Abstract]   [Full Text] [Related]  

  • 49. National Cancer Institute announces new study findings on breast-cancer treatment.
    Clin Pharm; 1988 Aug; 7(8):560. PubMed ID: 3168410
    [No Abstract]   [Full Text] [Related]  

  • 50. Adjuvant therapy for breast cancer.
    Henderson IC
    N Engl J Med; 1988 Feb; 318(7):443-4. PubMed ID: 3340122
    [No Abstract]   [Full Text] [Related]  

  • 51. [Weight gain under adjuvant chemotherapy].
    Bonneterre J; Vennin P; Demaille A
    Pathol Biol (Paris); 1989 Nov; 37(9):1012-3. PubMed ID: 2608324
    [No Abstract]   [Full Text] [Related]  

  • 52. Breast cancer therapy: exercising all our options.
    De Vita VT
    N Engl J Med; 1989 Feb; 320(8):527-9. PubMed ID: 2915656
    [No Abstract]   [Full Text] [Related]  

  • 53. Adjuvant systemic therapy for breast cancer.
    Love N; Robinson DS; Schwade JG
    Postgrad Med; 1989 Oct; 86(5):197-201, 204-6. PubMed ID: 2678061
    [No Abstract]   [Full Text] [Related]  

  • 54. [10 years' therapy of breast cancer].
    Schreml W
    Onkologie; 1986 Oct; 9 Suppl 2():49-56. PubMed ID: 3534674
    [No Abstract]   [Full Text] [Related]  

  • 55. High-dose adjuvant chemotherapy for high-risk breast cancer.
    Abeloff MD
    Recent Results Cancer Res; 1993; 127():177-83. PubMed ID: 8502814
    [No Abstract]   [Full Text] [Related]  

  • 56. Dose-intense adjuvant treatment of high-risk breast cancer.
    Bonadonna G; Valagussa P
    J Natl Cancer Inst; 1990 Apr; 82(7):542-3. PubMed ID: 2313728
    [No Abstract]   [Full Text] [Related]  

  • 57. [Availability and rational use of essential drugs in the treatment of cancer].
    Pavlovsky S; Muggia F; Sackmann Muriel F
    Bol Oficina Sanit Panam; 1985 Nov; 99(5):445-63. PubMed ID: 2937425
    [No Abstract]   [Full Text] [Related]  

  • 58. Subsets within the chemotherapy overview. International Breast Cancer Study Group.
    Coates AS; Gelber RD; Goldhirsch A
    Lancet; 1998 Nov; 352(9142):1783-4. PubMed ID: 9848379
    [No Abstract]   [Full Text] [Related]  

  • 59. The preclinical scientific basis for adjuvant chemotherapy in breast cancer.
    Griswold DP; Laster WR; Trader MW; Dykes DJ
    Recent Results Cancer Res; 1984; 96():1-7. PubMed ID: 6528086
    [No Abstract]   [Full Text] [Related]  

  • 60. Review: scientific basis of adjuvant chemotherapy in breast cancer.
    Griswold DP
    Recent Results Cancer Res; 1984; 96():46-7. PubMed ID: 6528091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.